BEXIX
Price
$15.07
Change
-$0.12 (-0.79%)
Updated
Jan 31 closing price
Net Assets
3.62B
VEMAX
Price
$36.94
Change
-$0.18 (-0.48%)
Updated
Jan 31 closing price
Net Assets
108.96B
Ad is loading...

BEXIX vs VEMAX

Header iconBEXIX vs VEMAX Comparison
Open Charts BEXIX vs VEMAXBanner chart's image
Baron Emerging Markets Institutional
Price$15.07
Change-$0.12 (-0.79%)
VolumeN/A
Net Assets3.62B
Vanguard Emerging Mkts Stock Idx Adm
Price$36.94
Change-$0.18 (-0.48%)
VolumeN/A
Net Assets108.96B
BEXIX vs VEMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BEXIX vs. VEMAX commentary
Feb 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEXIX is a StrongBuy and VEMAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 109B vs. BEXIX (3.62B). VEMAX pays higher dividends than BEXIX: VEMAX (3.43) vs BEXIX (0.67). BEXIX was incepted earlier than VEMAX: BEXIX (14 years) vs VEMAX (19 years). BEXIX is a more actively managed with annual turnover of: 33.37 vs. VEMAX (5.00). VEMAX has a lower initial minimum investment than BEXIX: VEMAX (3000) vs BEXIX (1000000). VEMAX annual gain was more profitable for investors over the last year : 13.85 vs. BEXIX (12.90). VEMAX return over 5 years is better than : 15.47 vs. BEXIX (8.67).
BEXIXVEMAXBEXIX / VEMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years19 years-
Gain YTD-0.067-0.16341%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets3.62B109B3%
Annual Yield % from dividends0.673.4320%
Returns for 1 year12.9013.8593%
Returns for 3 years-10.48-4.03260%
Returns for 5 years8.6715.4756%
Returns for 10 years31.2029.03107%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNVS3.660.16
+4.57%
Cineverse Corp
SABR3.390.08
+2.42%
Sabre Corp
PTCT46.150.93
+2.06%
PTC Therapeutics
OPRX5.710.05
+0.88%
OptimizeRx Corp
K81.940.17
+0.21%
Kellanova